NeuroThera Launches Yale Phase IIb Trial for Tourette Syndrome Treatment

Silexion Reports Three-Pathway Immune Sensitization in SIL204 Cancer Study

BridgerPay Says AI Rerouting Recovered $55 Million for Israeli Businesses

Selected story

InMode Holds Quarterly Revenue at $95.6 Million and Reaffirms 2026 Outlook

Odysight Signs Boeing Agreement to Demonstrate Predictive-Maintenance AI

Bezeq Raises 2026 Profit Forecast to as Much as NIS 1.2 Billion

InMode Holds Quarterly Revenue at $95.6 Million and Reaffirms 2026 Outlook

Something went wrong

We couldn't complete that action. Check your connection and try again.